Last Updated: June 17, 2026

Contract Pharmacal Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for CONTRACT PHARMACAL

CONTRACT PHARMACAL has twenty approved drugs.



Summary for Contract Pharmacal
US Patents:0
Tradenames:12
Ingredients:12
NDAs:20

Drugs and US Patents for Contract Pharmacal

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Contract Pharmacal CIMETIDINE cimetidine TABLET;ORAL 074963-001 Jun 19, 1998 DISCN No No ⤷  Start Trial ⤷  Start Trial
Contract Pharmacal IBUPROFEN ibuprofen TABLET;ORAL 071268-003 Jul 1, 1988 AB RX No No ⤷  Start Trial ⤷  Start Trial
Contract Pharmacal PREDNISONE prednisone TABLET;ORAL 080209-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial
Contract Pharmacal CIMETIDINE cimetidine TABLET;ORAL 074961-001 Jun 19, 1998 DISCN No No ⤷  Start Trial ⤷  Start Trial
Contract Pharmacal IBUPROFEN ibuprofen TABLET;ORAL 071268-001 Oct 15, 1986 AB RX No No ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.